Elsevier

The Spine Journal

Volume 14, Issue 9, 1 September 2014, Pages 2008-2018
The Spine Journal

Clinical Study
Obese Class III patients at significantly greater risk of multiple complications after lumbar surgery: an analysis of 10,387 patients in the ACS NSQIP database

https://doi.org/10.1016/j.spinee.2013.11.047Get rights and content

Abstract

Background context

Prior studies on the impact of obesity on spine surgery outcomes have focused mostly on lumbar fusions, do not examine lumbar discectomies or decompressions, and have shown mixed results regarding complications. Differences in sample sizes and body mass index (BMI) thresholds for the definition of the obese versus comparison cohorts could account for the inconsistencies in the literature.

Purpose

The purpose of the study was to analyze whether different degrees of obesity influence the complication rates in patients undergoing lumbar spine surgery.

Study design/setting

This was a retrospective cohort analysis of prospectively collected data using the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database from 2005 to 2010.

Patient sample

Patients in the de-identified, risk-adjusted, and multi-institutional ACS NSQIP database undergoing lumbar anterior fusion, posterior fusion, transforaminal lumbar interbody fusion/posterior lumbar interbody fusion (TLIF/PLIF), discectomy, or decompression were included.

Outcome measures

Primary outcome measures were 30-day postsurgical complications, including pulmonary embolism and deep vein thrombosis, death, system-specific complications (wound, pulmonary, urinary, central nervous system, and cardiac), septic complications, and having one or more complications overall. Secondary outcomes were time spent in the operating room, blood transfusions, length of stay, and reoperation within 30 days.

Methods

Patients undergoing lumbar anterior fusion, posterior fusion, TLIF/PLIF, discectomy, or decompression in the ACS NSQIP, 2005 to 2010, were categorized into four BMI groups: nonobese (18.5–29.9 kg/m2), Obese I (30–34.9 kg/m2), Obese II (35–39.9 kg/m2), and Obese III (greater than or equal to 40 kg/m2). Obese I to III patients were compared with patients in the nonobese category using chi-square test and analysis of variance. Multivariate linear/logistic regression models were used to adjust for preoperative risk factors.

Results

Data were available for 10,387 patients undergoing lumbar surgery. Of these, 4.5% underwent anterior fusion, 17.9% posterior fusion, 6.3% TLIF/PLIF, 40.7% discectomy, and 30.5% decompression. Among all patients, 25.6% were in the Obese I group, 11.5% Obese II, and 6.9% Obese III. On multivariate analysis, Obese I and III had a significantly increased risk of urinary complications, and Obese II and III patients had a significantly increased risk of wound complications. Only Obese III patients, however, had a statistically increased risk of having increased time spent in the operating room, an extended length of stay, pulmonary complications, and having one or more complications (all p<.05).

Conclusions

Patients with high BMI appear to have higher complication rates after lumbar surgery than patients who are nonobese. However, the complication rates seem to increase substantially for Obese III patients. These patients have longer times spent in the operating room, extended hospitals stays, and an increased risk for wound, urinary, and pulmonary complications and for having at least one or more complications overall. Surgeons should be aware of the increased risk of multiple complications for patients with BMI greater than or equal to 40 kg/m2.

Introduction

Evidence & Methods

As complications following surgery receive increased scrutiny from the public, government and third-party payers, the ability to risk adjust and prognosticate outcomes in the setting of specific medical co-morbidities is becoming increasingly vital. At this time, the impact of obesity on outcomes after lumbar spine surgery remains controversial. The authors sought to address this issue by analyzing data from the National Surgical Quality Improvement Program (NSQIP).

The authors analyzed more than 10,000 cases of lumbar spine surgery. They classified obesity using the WHO graded scale and concluded that patients with WHO grade III obesity were at an increased risk of complications as well as extended length of hospital stay.

The authors’ findings add to a growing body of literature detailing the deleterious effect of obesity on outcomes following spine surgery. This is necessary information for patients, physicians, hospital administrators and third-party payers. At a minimum, the study’s findings can be used to better inform patients at the time of surgical consent regarding the anticipated impact of obesity on outcomes. As this information was derived from a national registry intended for quality improvement purposes, it suffers from the possibility of confounding due to errors in coding as well as missing data. In addition, the number of complication events as compared to the sample size is invariably restricted and, given the number of covariates the authors included in their regressions, the model may be overfit. Only scientifically rigorous, prospective, comparative research can truly provide high quality evidence to better inform this issue.

—The Editors

Obesity is a national epidemic. According to the Centers for Disease Control and Prevention, 78 million (35.7% of the population) of US adults are currently obese (body mass index [BMI] greater than or equal to 30 kg/m2) [1]. The high prevalence of obesity has led to an increase in obesity-related complications, including back pain and degeneration of the lumbar spine [2], [3], [4]. As a result, more patients with high BMI are presenting to spine surgeons, and there has thus been a growing interest in understanding the complication risks after lumbar surgery in this patient population.

Several related single-institution and population-based studies have been conducted, but results have been mixed. Some studies have shown no increased risk after lumbar surgery in obese patients [5], [6], [7], particularly after minimally invasive surgery (MIS) [8], [9], [10], whereas most have noted an association between high BMI and an increased risk of complications [11], [12], [13], [14], [15]. Specifically, a few studies have found the obese population to have a higher rate of wound complications [11], [12], [14], [16], [17], deep vein thromboses (DVTs) [11], [13], reoperation [18], intraoperative blood loss [15], [16], [17], [19], extended hospital stays, and longer operative times [19].

Possible explanations for the inconsistency in the literature may lie in sample size differences and the fact that different BMI thresholds were used to define the obese and comparison cohorts. Most related studies defined obesity as BMI greater than or equal to 30 kg/m2, but some compared the obese group with a nonobese group (BMI less than 30 kg/m2) [16], [19], others with a normal weight group (BMI=18.5–24.9 kg/m2) [20], and others with both a normal group and an overweight group (BMI=25–29.9 kg/m2) [6]. One large-scale multi-institutional study compared a morbidly obese group (BMI greater than or equal to 40 kg/m2) with a normal-weight group (defined in their study by the absence of International Classification of Diseases, Ninth Revision [ICD-9] codes for obesity, overweight, or underweight) [11], whereas another study compared obese (BMI=30–39.9 kg/m2) and morbidly obese (BMI greater than or equal to 40 kg/m2) patients to a normal or overweight group (defined in their study by the absence of ICD-9 codes for obesity and morbid obesity) [17]. There was one study that used a nonstandard definition for obese (BMI greater than or equal to 35 kg/m2) and nonobese (BMI less than 35 kg/m2) [18]. Other smaller studies also differed in their definitions of obesity [2], [3], [10], [12], [14], [15], [21], [22].

Given the different BMI thresholds used for defining obesity and the mixed results of the studies, the question arises as to what degree of obesity is actually associated with which adverse outcomes. The World Health Organization (WHO) has a graded scale for obesity: Obese I (30–34.9 kg/m2), Obese II (35–39.9 kg/m2), and Obese III (greater than or equal to 40 kg/m2). Nonetheless, only one of the smaller studies has used this graded scale of obesity in the analysis of spinal fusion complications [14]. To our knowledge, no large lumbar surgery study has used this graded definition of obesity for this purpose. Furthermore, most studies have mostly focused on lumbar fusions, and there are limited data comparing complications for different types of lumbar surgery.

The present study is a large-scale multi-institutional database study using the American College of Surgeons National Surgery Quality Improvement Program (ACS NSQIP) database. National databases are increasingly being used to address clinical questions with degrees of randomization, speed, and power previously not possible. Each database measures different variables and has its specific advantages and limitations to answer clinical questions, particularly for short-term postoperative outcomes. With the use of ACS NSQIP, this study characterizes and compares the 30-day clinical outcomes of patients with graded levels of obesity after five common lumbar spine surgery procedures. Results are compared with currently available literature.

Section snippets

Data source/study population

The ACS NSQIP is a prospective, risk-adjusted, multi-institutional outcome program whose details of data collection strategies, inclusion criteria, sampling procedures, and outcomes measured have been reported [23], [24], [25], [26]. The ACS NSQIP collects data on 135 Health Insurance Portability and Accountability Act–compliant variables, including preoperative comorbidities, intraoperative variables, and 30-day postoperative morbidity and mortality outcomes for patients undergoing major

Patient population

From the NSQIP database, we identified 10,387 patients who underwent lumbar spine surgery with the following distribution of procedures: 472 anterior fusions (4.5%); 1,861 posterior fusions (17.9%); 650 TLIF/PLIFs (6.3%); 4,231 discectomies (40.7%); and 3,173 decompressions (30.5%). Based on BMI, 5,813 patients (56%) were nonobese, 2,660 obese Class I (25.6%), 1,198 obese Class II (11.5%), and 716 obese Class III (6.9%).

Differences in patient demographic and clinical characteristics by BMI are

Discussion

This study examined the 30-day clinical outcomes from five common lumbar spine procedures in patients with scaled BMI levels. After adjusting for possible confounders, we showed that complication rates were relatively low for Classes I and II obesity but had a significant stepped increase for Class III obesity patients, particularly for wound complications.

Although prior studies have examined the impact of BMI on operative outcomes after lumbar surgery, ours is the first multi-institutional,

References (34)

  • A. Schoenfeld et al.

    Risk factors for immediate postoperative complications and mortality following spine surgery: a study of 3475 patients from the national surgical quality improvement program

    J Bone Joint Surg Am

    (2011)
  • D. Rosen et al.

    Obesity and self-reported outcome after minimally invasive lumbar spinal fusion surgery

    Neurosurgery

    (2008)
  • J. Cole et al.

    Minimally invasive lumbar discectomy in obese patients

    Neurosurgery

    (2007)
  • W. Senker et al.

    Perioperative morbidity and complications in minimal access surgery techniques in obese patients with degenerative lumbar disease

    Eur Spine J

    (2011)
  • P. Kalanithi et al.

    Morbid obesity increases cost and complication rates in spinal arthrodesis

    Spine

    (2012)
  • M. Djurasovic et al.

    The effect of obesity on clinical outcomes after lumbar fusion

    Spine

    (2008)
  • S. Fineberg et al.

    The incidence and mortality of thromboembolic events in lumbar spine surgery

    Spine

    (2013)
  • Cited by (0)

    FDA device/drug status: Not applicable.

    Author disclosures: RAB: Nothing to disclose. MCF: Nothing to disclose. JAG: Nothing to disclose. WDL: Nothing to disclose. JNG: Consulting: Affinergy (D, Paid directly to employer), Alphatec (E, Paid directly to employer), Depuy (C, Paid directly to employer), Harvard Clinical Research Institute (B, Paid directly to employer), KCI (B, Paid directly to employer), Powered Research (A, Paid directly to employer), Stryker (E, Paid directly to employer), Transgenomic (Paid directly to employer); Grants: Smith and Nephew (Genetic tests performed by them only and no funds exchanged, Paid directly to institution).

    The disclosure key can be found on the Table of Contents and at www.TheSpineJournalOnline.com.

    The authors report no sources of funding or conflicts of interest related to this study.

    View full text